MENU
+Compare
ACHFF
Stock ticker: OTC
AS OF
Nov 18 closing price
Price
$0.73
Change
+$0.01 (+1.39%)
Capitalization
49.8M

ACHFF Arch Biopartners Inc. Forecast, Technical & Fundamental Analysis

Arch Biopartners Inc is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation... Show more

ACHFF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ACHFF with price predictions
Nov 18, 2025

ACHFF in +2.15% Uptrend, rising for three consecutive days on November 11, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ACHFF advanced for three days, in of 195 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ACHFF's RSI Oscillator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 29, 2025. You may want to consider a long position or call options on ACHFF as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ACHFF just turned positive on October 24, 2025. Looking at past instances where ACHFF's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where ACHFF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACHFF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ACHFF entered a downward trend on October 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ACHFF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (23.122). P/E Ratio (0.000) is within average values for comparable stocks, (61.014). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.073). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (332.704).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACHFF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ACHFF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
545 King Street West
Phone
+1 647 428-7031
Employees
N/A
Web
https://www.archbiopartners.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCGFF10.12N/A
N/A
Credit Corp Group Ltd.
CBAF31.30N/A
N/A
Citba Financial Corp.
CLNXF30.17N/A
N/A
Cellnex Telecom SA
TLPFY32.65-0.46
-1.39%
Teleperformance
ORLCF0.03N/A
-1.68%
ORACLE COMMODITY HLDG CORP

ACHFF and Stocks

Correlation & Price change

A.I.dvisor tells us that ACHFF and LABFF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACHFF and LABFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHFF
1D Price
Change %
ACHFF100%
+0.53%
LABFF - ACHFF
21%
Poorly correlated
N/A
ARGNF - ACHFF
11%
Poorly correlated
N/A
AGTX - ACHFF
4%
Poorly correlated
N/A
ADCT - ACHFF
4%
Poorly correlated
+0.76%
INBX - ACHFF
3%
Poorly correlated
+0.58%
More